SCHEMBL10909707

SCHEMBL10909707

O=C(Nc1ccc(C(=O)Nc2cc(O)c(S(=O)(=O)O)c3ccccc23)cc1)C(=O)Nc1ccc(C(=O)Nc2cc(O)c(S(=O)(=O)O)c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD40 P25942 1/20 0.45
▸ CD40LG P29965 1/20 0.45
▸ CA2 P00918 7/20 0.43
▸ APEX1 P27695 1/20 0.43
▸ HDAC1 Q13547 1/20 0.42
▸ CA1 P00915 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CCR8 P51685 1/20 0.41
▸ TIMP3 P35625 1/20 0.41
▸ CTDSP1 Q9GZU7 2/20 0.40
▸ TERT O14746 1/20 0.40
▸ TOP1 P11387 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ PSMD14 O00487 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11344807 0.93 TIMP3 (0.48) CD40CD40LGCA2APEX1HDAC1
SCHEMBL10907651 0.88 NPC1 (0.45) APEX1MEN1KMT2ACCR8TIMP3
SCHEMBL11428577 0.86 HDAC1 (0.51) CA2APEX1HDAC1CA1MEN1
SCHEMBL10908002 0.83 DHODH (0.43) MEN1KMT2ATERTTOP1POLB
SCHEMBL10907563 0.82 CD40 (0.50) CD40CD40LGCA2APEX1MEN1
SCHEMBL10907840 0.82 CD40 (0.43) CD40CD40LGCA2CA1MEN1
SCHEMBL10907614 0.82 LMNA (0.41) MEN1KMT2AHPGDPOLBMAPT
SCHEMBL11423374 0.82 NPC1 (0.60) CD40CD40LGMEN1KMT2ACTDSP1
SCHEMBL11350051 0.81 KMT2A (0.53) APEX1MEN1KMT2ATIMP3POLB
SCHEMBL10976824 0.81 CYP2D6 (0.49) CD40CD40LGCA2APEX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4599204-A Oxalylamides useful as dental antiplaque agents and inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1986-07-08 — — US disclosed
Send feedback